A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients

Figure 2

Prognostic analysis of the characteristic models of 8 genes in the TCGA cohort. (a) The distribution and median value of the risk score in the TCGA cohort. (b) The distributions of OS condition, OS, and risk score in the TCGA queue. (e) Kaplan-Meier curves of OS in the high- and low-risk TCGA cohorts for HCC patients. (c) PC plot of the TCGA cohort. (d) t-SNE analysis of the TCGA cohort. (f) The area under the curve of time-dependent ROC curves validated the prognostic manifestation of the risk score in the TCGA.

(a)

(b)

(c)

(d)

(e)

(f)